SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-08-014461
Filing Date
2008-06-05
Accepted
2008-06-05 17:19:39
Documents
1
Period of Report
2008-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4197
  Complete submission text file 0001140361-08-014461.txt   6064
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 1341 COLUMBUS AVENUE BURLINGAME CA 94010
Business Address 650-343-5656
Wells James A (Reporting) CIK: 0001321448 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 08883824